IJMS, Free Full-Text
By A Mystery Man Writer
Description
Skeletal disorders, such as osteoarthritis and bone fractures, are among the major conditions that can compromise the quality of daily life of elderly individuals. To treat them, regenerative therapies using skeletal cells have been an attractive choice for patients with unmet clinical needs. Currently, there are two major strategies to prepare the cell sources. The first is to use induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs), which can recapitulate the skeletal developmental process and differentiate into various skeletal cells. Skeletal tissues are derived from three distinct origins: the neural crest, paraxial mesoderm, and lateral plate mesoderm. Thus, various protocols have been proposed to recapitulate the sequential process of skeletal development. The second strategy is to extract stem cells from skeletal tissues. In addition to mesenchymal stem/stromal cells (MSCs), multiple cell types have been identified as alternative cell sources. These cells have distinct multipotent properties allowing them to differentiate into skeletal cells and various potential applications for skeletal regeneration. In this review, we summarize state-of-the-art research in stem cell differentiation based on the understanding of embryogenic skeletal development and stem cells existing in skeletal tissues. We then discuss the potential applications of these cell types for regenerative medicine.
IJMS, Free Full-Text, artemisia annua
Irwin I. Puc, PhD on LinkedIn: New Paper 📄 IJMS
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-15-03842/article_deploy/html/images/ijms-15-03842f1-1024.png)
IJMS, Free Full-Text, nmm para nm
![IJMS, Free Full-Text](http://www.mdpi.com/ijms/ijms-21-00301/article_deploy/html/images/ijms-21-00301-g001.png)
IJMS, Free Full-Text, kit lamine sci
![IJMS, Free Full-Text](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbmt.2017.228/MediaObjects/41409_2018_Article_BFbmt2017228_Fig1_HTML.jpg)
IJMS Free Full-Text C-Reactive Protein As A Biomarker For, 54% OFF
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-24-12649/article_deploy/html/images/ijms-24-12649-g001.png)
IJMS, Free Full-Text, kit lamine sci
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-22-00289/article_deploy/html/images/ijms-22-00289-g001.png)
IJMS, Free Full-Text, kurnik login
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-24-15978/article_deploy/html/images/ijms-24-15978-g001-550.jpg)
IJMS, Free Full-Text, o que significa cgc/mf
![IJMS, Free Full-Text](https://pub.mdpi-res.com/ijms/ijms-14-16168/article_deploy/html/images/ijms-14-16168f1-1024.png?1403147020)
IJMS, Free Full-Text, nmm para nm
![IJMS, Free Full-Text](https://pub.mdpi-res.com/ijms/ijms-20-05018/article_deploy/html/images/ijms-20-05018-ag.png?1572465198)
IJMS, Free Full-Text, niemann pick disease
![IJMS, Free Full-Text](https://pub.mdpi-res.com/ijms/ijms-12-07114/article_deploy/html/images/ijms-12-07114f1-1024.png?1403143409)
IJMS, Free Full-Text, nmm para nm
![IJMS, Free Full-Text](https://pub.mdpi-res.com/ijms/ijms-24-00371/article_deploy/html/images/ijms-24-00371-g001.png?1672916704)
IJMS, Free Full-Text, Carrageenan
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-24-01703/article_deploy/html/images/ijms-24-01703-g001.png)
IJMS, Free Full-Text, kit lamine sci
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-13-17210/article_deploy/html/images/ijms-13-17210f1-1024.png)
IJMS, Free Full-Text, spider silk tibia
![IJMS, Free Full-Text](https://www.mdpi.com/ijms/ijms-21-01247/article_deploy/html/images/ijms-21-01247-g0A1.png)
IJMS, Free Full-Text, bäumlein 108 led
from
per adult (price varies by group size)